Author Correction: A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA

Anna-Lisa Doebley^{1

2

3}, Minjeong Ko¹, Hanna Liao^{2

4}, A Eden Cruikshank^{1

2}, Katheryn Santos⁵, Caroline Kikawa³, Joseph B Hiatt^{1

6}, Robert D Patton¹, Navonil De Sarkar¹, Katharine A Collier⁷, Anna C H Hoge¹, Katharine Chen², Anat Zimmer¹, Zachary T Weber⁷, Mohamed Adil^{1

8}, Jonathan B Reichel^{1

8

9}, Paz Polak¹⁰, Viktor A Adalsteinsson¹¹, Peter S Nelson^{1

4

6

8

9}, David MacPherson^{1

4}, Heather A Parsons⁵, Daniel G Stover⁷, Gavin Ha^{12

13

14}

Affiliations

¹ Division of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.
² Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA.
³ Medical Scientist Training Program, University of Washington, Seattle, WA, USA.
⁴ Department of Genome Sciences, University of Washington, Seattle, WA, USA.
⁵ Dana-Farber Cancer Institute, Boston, MA, USA.
⁶ Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁷ Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
⁸ Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
⁹ Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
¹⁰ Department of Oncological Sciences, Icahn School of Medicine, Mount Sinai, New York, NY, USA.
¹¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
¹² Division of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA. gha@fredhutch.org.
¹³ Department of Genome Sciences, University of Washington, Seattle, WA, USA. gha@fredhutch.org.
¹⁴ Brotman Baty Institute for Precision Medicine, Seattle, WA, USA. gha@fredhutch.org.

Published Erratum

Anna-Lisa Doebley et al. Nat Commun. 2023.

. 2023 Jan 25;14(1):403.

doi: 10.1038/s41467-023-36187-8.

¹ Division of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA.
² Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA.
³ Medical Scientist Training Program, University of Washington, Seattle, WA, USA.
⁴ Department of Genome Sciences, University of Washington, Seattle, WA, USA.
⁵ Dana-Farber Cancer Institute, Boston, MA, USA.
⁶ Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁷ Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
⁸ Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
⁹ Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
¹⁰ Department of Oncological Sciences, Icahn School of Medicine, Mount Sinai, New York, NY, USA.
¹¹ Broad Institute of MIT and Harvard, Cambridge, MA, USA.
¹² Division of Public Health Sciences and Human Biology, Fred Hutchinson Cancer Center, Seattle, WA, USA. gha@fredhutch.org.
¹³ Department of Genome Sciences, University of Washington, Seattle, WA, USA. gha@fredhutch.org.
¹⁴ Brotman Baty Institute for Precision Medicine, Seattle, WA, USA. gha@fredhutch.org.

No abstract available

Erratum for

A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA.
Doebley AL, Ko M, Liao H, Cruikshank AE, Santos K, Kikawa C, Hiatt JB, Patton RD, De Sarkar N, Collier KA, Hoge ACH, Chen K, Zimmer A, Weber ZT, Adil M, Reichel JB, Polak P, Adalsteinsson VA, Nelson PS, MacPherson D, Parsons HA, Stover DG, Ha G. Doebley AL, et al. Nat Commun. 2022 Dec 3;13(1):7475. doi: 10.1038/s41467-022-35076-w. Nat Commun. 2022. PMID: 36463275 Free PMC article.